**Patient Discharge Summary**

**Patient Information**

* Name: John Doe
* Date of Birth: January 10, 1975
* Admission Date: March 15, 2023
* Discharge Date: March 25, 2023
* Patient ID: 123456

**Chief Complaint and Reason for Admission**

John Doe, a 48-year-old male, was admitted to the endocrinology unit on March 15, 2023, with a chief complaint of increasing thirst, frequent urination, and fatigue over the past three months. His primary care physician referred him to our hospital for further evaluation and management of suspected type 2 diabetes.

**Initial Evaluation and Diagnosis**

Upon admission, the patient underwent a comprehensive medical evaluation, including a physical examination, laboratory tests, and medical history review. Laboratory tests revealed a fasting plasma glucose (FPG) level of 240 mg/dL (> 11.1 mmol/L) and a glycosylated hemoglobin (HbA1C) level of 8.2%. These values confirmed the diagnosis of type 2 diabetes.

**Treatment and Management**

The patient was started on a treatment plan consisting of diet, exercise, and medications. He was prescribed metformin 500 mg twice daily, which was titrated up to 1000 mg twice daily based on his blood glucose levels. Additionally, he was advised to engage in at least 150 minutes of moderate-intensity aerobic exercise per week, with adjustments for hypoglycemia risk.

**Medications**

* Metformin 1000 mg twice daily
* Insulin glargine 10 units at bedtime (initiated on day 7 of hospital stay)
* Aspirin 81 mg daily (initiated on day 5 of hospital stay)

**Laboratory Results**

* FPG: 140 mg/dL (> 7.8 mmol/L)
* HbA1C: 6.5% (confirmed diagnosis of type 2 diabetes)
* Lipid profile: total cholesterol 180 mg/dL, HDL cholesterol 40 mg/dL, LDL cholesterol 90 mg/dL, triglycerides 120 mg/dL
* Serum creatinine: 1.2 mg/dL
* Urine testing for albuminuria: negative

**Patient Education**

The patient received comprehensive education on the causes of diabetes, symptoms and signs of hypoglycemia and hyperglycemia, and diabetic complications. He was also educated on adjusting insulin doses based on blood glucose levels and carbohydrate intake. The patient was advised to monitor his blood glucose levels regularly and to adjust his insulin doses accordingly. He was also educated on the importance of regular physical activity and a balanced diet.

**Dietary Recommendations**

The patient was advised to follow a balanced diet that focuses on whole foods and high-quality carbohydrates. He was also advised to limit his intake of sugary drinks and foods high in added sugars.

**Physical Activity**

The patient was advised to engage in at least 150 minutes of moderate-intensity aerobic exercise per week, with adjustments for hypoglycemia risk. He was also advised to incorporate resistance exercise into his routine to improve overall health and well-being.

**Follow-up and Monitoring**

The patient was scheduled for follow-up appointments with his primary care physician and endocrinologist in two weeks to monitor his blood glucose levels and adjust his treatment plan as needed. He was also advised to return to the hospital if he experiences any symptoms of hypoglycemia or hyperglycemia.

**Discharge Summary**

John Doe was discharged from the hospital on March 25, 2023, in a stable condition. He was advised to follow the treatment plan outlined above and to monitor his blood glucose levels regularly. He was also advised to return to the hospital if he experiences any symptoms of hypoglycemia or hyperglycemia.

**Conclusion**

John Doe was diagnosed with type 2 diabetes and received comprehensive treatment and management. He was educated on the causes of diabetes, symptoms and signs of hypoglycemia and hyperglycemia, and diabetic complications. He was also advised to follow a balanced diet and engage in regular physical activity to improve his overall health and well-being. The patient was discharged from the hospital in a stable condition and was advised to follow up with his primary care physician and endocrinologist in two weeks.